Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease

David S. Snyder, Lukmanee Tradtrantip, Chenjuan Yao, Mark J. Kurth, A. S. Verkman

Research output: Contribution to journalArticlepeer-review

65 Scopus citations

Fingerprint Dive into the research topics of 'Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences